These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 17320279

  • 1. PKC inhibitor Go6976 induces mitosis and enhances doxorubicin-paclitaxel cytotoxicity in urinary bladder carcinoma cells.
    Aaltonen V, Koivunen J, Laato M, Peltonen J.
    Cancer Lett; 2007 Aug 08; 253(1):97-107. PubMed ID: 17320279
    [Abstract] [Full Text] [Related]

  • 2. The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints.
    Kohn EA, Yoo CJ, Eastman A.
    Cancer Res; 2003 Jan 01; 63(1):31-5. PubMed ID: 12517773
    [Abstract] [Full Text] [Related]

  • 3. Protein kinase C alpha/beta inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells.
    Koivunen J, Aaltonen V, Koskela S, Lehenkari P, Laato M, Peltonen J.
    Cancer Res; 2004 Aug 15; 64(16):5693-701. PubMed ID: 15313909
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of protein kinase Calpha enhances anticancer agent-induced loss of anchorage-independent growth regardless of protection against apoptosis by Bcl-2.
    Huigsloot M, Tijdens RB, van de Water B.
    Mol Pharmacol; 2003 Oct 15; 64(4):965-73. PubMed ID: 14500753
    [Abstract] [Full Text] [Related]

  • 5. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R.
    Clin Cancer Res; 2002 Nov 15; 8(11):3512-9. PubMed ID: 12429642
    [Abstract] [Full Text] [Related]

  • 6. Impaired gap junction formation and intercellular calcium signaling in urinary bladder cancer cells can be improved by Gö6976.
    Leinonen P, Aaltonen V, Koskela S, Lehenkari P, Korkiamäki T, Peltonen J.
    Cell Commun Adhes; 2007 Oct 15; 14(4):125-36. PubMed ID: 17957529
    [Abstract] [Full Text] [Related]

  • 7. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
    Poon RY, Chau MS, Yamashita K, Hunter T.
    Cancer Res; 1997 Nov 15; 57(22):5168-78. PubMed ID: 9371520
    [Abstract] [Full Text] [Related]

  • 8. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y, Buffolino P, Coppock DL.
    Exp Cell Res; 1998 Aug 01; 242(2):381-90. PubMed ID: 9683525
    [Abstract] [Full Text] [Related]

  • 9. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P, Robey R, Fojo T, Blagosklonny MV.
    Oncogene; 2001 Jun 28; 20(29):3806-13. PubMed ID: 11439344
    [Abstract] [Full Text] [Related]

  • 10. PKCalpha/beta I inhibitor Go6976 induces dephosphorylation of constitutively hyperphosphorylated Rb and G1 arrest in T24 cells.
    Aaltonen V, Peltonen J.
    Anticancer Res; 2010 Oct 28; 30(10):3995-9. PubMed ID: 21036713
    [Abstract] [Full Text] [Related]

  • 11. Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells.
    Yih LH, Hsueh SW, Luu WS, Chiu TH, Lee TC.
    Carcinogenesis; 2005 Jan 28; 26(1):53-63. PubMed ID: 15471901
    [Abstract] [Full Text] [Related]

  • 12. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
    Shah BH, Olivares-Reyes JA, Catt KJ.
    Mol Pharmacol; 2005 Jan 28; 67(1):184-94. PubMed ID: 15465928
    [Abstract] [Full Text] [Related]

  • 13. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH, el-Naggar AK, Priebe W, Perez-Soler R.
    Mol Pharmacol; 1996 May 28; 49(5):832-41. PubMed ID: 8622633
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines.
    Supiot S, Gouard S, Charrier J, Apostolidis C, Chatal JF, Barbet J, Davodeau F, Cherel M.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 2):7047s-7052s. PubMed ID: 16203801
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of Taxol-induced cell death are concentration dependent.
    Torres K, Horwitz SB.
    Cancer Res; 1998 Aug 15; 58(16):3620-6. PubMed ID: 9721870
    [Abstract] [Full Text] [Related]

  • 16. Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line.
    Barboule N, Chadebech P, Baldin V, Vidal S, Valette A.
    Oncogene; 1997 Dec 04; 15(23):2867-75. PubMed ID: 9419978
    [Abstract] [Full Text] [Related]

  • 17. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.
    Aranha O, Wood DP, Sarkar FH.
    Clin Cancer Res; 2000 Mar 04; 6(3):891-900. PubMed ID: 10741713
    [Abstract] [Full Text] [Related]

  • 18. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK.
    Clin Cancer Res; 2000 Apr 04; 6(4):1498-507. PubMed ID: 10778982
    [Abstract] [Full Text] [Related]

  • 19. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Qamar L, Davis R, Anwar A, Behbakht K.
    Gynecol Oncol; 2008 Sep 04; 110(3):425-31. PubMed ID: 18619662
    [Abstract] [Full Text] [Related]

  • 20. Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy.
    Sui M, Dziadyk JM, Zhu X, Fan W.
    Clin Cancer Res; 2004 Jul 15; 10(14):4848-57. PubMed ID: 15269161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.